ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Isala at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Isala takes part in 3 sessions at ESMO 2026 in Madrid. Its sessions centre on adjusting cancer drug infusions and dosing schedules. They examine nivolumab dosing intervals, pembrolizumab infusion reactions, and faster rituximab infusions.
| Organization | ESMO 2026 Attendance |
|---|---|
Isala Zwolle, Netherlands | |
Teaching hospital with an oncology center in Zwolle, Netherlands. | Poster Fri Oct 23 13:00–15:00 Optimizing oncology care: A pharmacokinetics-driven approach to extending nivolumab dosing intervals Gastrointestinal cancersMelanoma & skin cancersGenitourinary cancersNursing & supportive care Poster Sat Oct 24 12:00–12:45 Incidence of IRRs in 10-minute pembrolizumab infusion in everyday oncology practice Gastrointestinal cancersGynaecological cancersLung & thoracic cancersBreast cancerMelanoma & skin cancersGenitourinary cancersNursing & supportive care Poster Mon Oct 26 12:00–12:45 Accelerated rituximab infusion up to 15 minutes in haematological malignancies: A prospective pilot study Haematological malignanciesNursing & supportive care |
Find decision makers at Isala
Tell us what you sell and we’ll find the people at Isala most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction